{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:51:21Z","timestamp":1773895881608,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T00:00:00Z","timestamp":1096502400000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Well\u2010known cutaneous side effects of interferon (IFN)\u2010alfa therapy include dry skin, pruritus, hair loss, and psoriasis. Presumably because of its potent immunomodulatory activity, the use of IFN\u2010alfa has also led to the development of autoimmune diseases in susceptible individuals. Vitiligo, an autoimmune cutaneous disease, has been reported to occur during IFN\u2010alfa therapy. We report a 10\u2010year\u2010old girl with chronic hepatitis B infection in whom IFN\u2010alfa treatment induced de novo development of vitiligo and psoriasis. Neither skin condition improved after withdrawal of interferon treatment. Concomitant occurrence of vitiligo and psoriasis due to IFN\u2010alfa has not been reported previously.<\/jats:p>","DOI":"10.1111\/j.0736-8046.2004.21512.x","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T08:33:19Z","timestamp":1104222799000},"page":"577-579","source":"Crossref","is-referenced-by-count":51,"title":["Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa\u20102a for Chronic Hepatitis B Infection"],"prefix":"10.1111","volume":"21","author":[{"given":"Deniz","family":"Se\u00e7kin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7i\u00e7ek","family":"Durusoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedef","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,30]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70078-5"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360507"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91382-3"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.467"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb03461.x"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91502-3"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.896.365"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00655-4.x"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb14774.x"},{"key":"e_1_2_4_11_2","first-page":"1756","article-title":"Exacerbation of psoriasis due to interferon\u2010\u03b1 treatment of chronic active hepatitis","volume":"88","author":"Georgetson MJ","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(99)80095-X"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246208"},{"key":"e_1_2_4_14_2","first-page":"289","article-title":"Vitiligo associated with alpha\u2010interferon in a patient with chronic active hepatitis C","volume":"60","author":"Nouri K","year":"1997","journal-title":"Cutis"},{"key":"e_1_2_4_15_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2340\/0001555563246249","article-title":"Psoriasis and vitiligo","volume":"63","author":"Powell FC","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_4_16_2","volume-title":"Textbook of clinical hepatology","author":"Bircher J","year":"1999"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0736-8046.2004.21512.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0736-8046.2004.21512.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T22:13:14Z","timestamp":1697148794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0736-8046.2004.21512.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.0736-8046.2004.21512.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21512.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}